Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.
Evoked potential tests in clinical diagnosis.
A new model for primary-progressive multiple sclerosis?
Vitamin D in inflammatory diseases.
Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.
[Progressive multifocal leukoencephalopathy (review)].
Utility of the rio score and modified rio score in korean patients with multiple sclerosis.
Using Observational Analysis of Multiple Sclerosis Relapse to Design Outcomes-Based Contracts for Disease-Modifying Drugs: A Feasibility Assessment.
Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity.
Tried-and-True Antibiotic May Block Conversion to MS
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.
B-cell targeted therapeutics in clinical development.
Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
Quantitative metabolic profiling of lipid mediators.
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
Impaired decision-making and diffusion orientational complexity in people with multiple sclerosis.
Temperature dependence of water diffusion pools in brain white matter.

Pages